Index


in long-term parenteral nutrition, 82b in metabolic bone disease, 77 and potassium levels, 121b in refeeding syndrome, 65, 66, 80


malabsorption, 6b home parenteral nutrition in, 10, 89b


refeeding syndrome risk in, 65b malnutrition, 5, 9 electrolyte requirements in, 36 initiation of parenteral nutrition in, 8


liver disease in, 68 refeeding syndrome in, 65, 65b risk for complications in, 60


manganese, 41, 43 as contaminant, 81, 83b daily requirements for, 42b laboratory monitoring of, 57t, 81 in liver disease, 76b in long-term parenteral nutrition, 81, 83b


toxicity of, 76, 81, 83b


Medicaid, 91 Medicare, 91–92, 92b, 93b medications, 45 bone loss from, 78, 78b hepatotoxic, 77b in home parenteral nutrition, 94 hypertriglyceridemia from, 61, 63b


metabolic disorders, 73–84 acidosis in, 38, 39, 78, 78b alkalosis in, 38, 39 bone disease in, 77–78, 78b, 111 glucose blood levels in, 79 in home parenteral nutrition, 77, 101, 104b, 111


liver disease in, 73–75 refeeding syndrome in, 80 triglyceride levels in, 79–80


micronutrients in liver disease, 75, 76b in long-term parenteral nutrition, 80–81


midline catheters, 21–22 minerals in osmolarity calculation, 16b monitoring of electrolyte levels, 37, 57t of fluid balance, 109 in follow-up appointments, 110b, 110–111 in home parenteral nutrition, 96, 99–111


laboratory tests in, 56, 57t, 107, 108b 130


in Nutrition Care Process, 2 of quality of life, 109


motility disorders, gastrointestinal, 7b, 107 home parenteral nutrition in, 10, 89b, 91, 92b


multi-chamber bag parenteral nutrition, 46, 50, 50b multidisciplinary team in home parenteral nutrition, 87–89


National Center for Health Statistics, 73


National Organization for Rare Disorders, 107


National Scleroderma Foundation, 107 neonatal parenteral nutrition, 43, 45 nerve injury, 23b niacin (vitamin B3), 41b nitrogen, 33, 74b nonadherence to home parenteral nutrition, 101 nutrition assessment, 2–3, 3b, 55–56 in home parenteral nutrition, 93, 109 in long-term parenteral nutrition, 79, 80


Nutrition Care Process, 1–2, 3 nutrition diagnosis, 2, 3 nutrition interventions, 2, 3 nutrition monitoring, 2 nutrition support team, 87–89


occlusion of central venous catheters, 23b, 24b, 105b oils, cutaneous, in essential fatty acid deficiency, 36 oils, in intravenous lipid emulsions, 34, 35–36 allergic reaction to, 35–36, 69 in home parenteral nutrition, 80 and hypertriglyceridemia, 63, 80 and liver disease, 75, 75b in long-term parenteral nutrition, 75, 80, 82b, 84b mixture of, 34, 35t, 63, 75, 84b


Oley Foundation, 107, 109 olive oil, 34, 35t, 36, 63 allergic reaction to, 69


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149